Nipro Corporation (8086) - Financial and Strategic SWOT Analysis Review

Date: July 5, 2016
Pages: 48
Price:
US$ 125.00
License [?]:
Publisher: GlobalData
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: NAB21C8878CEN
Leaflet:

Download PDF Leaflet

Nipro Corporation (8086) - Financial and Strategic SWOT Analysis Review
Nipro Corporation (8086) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:
  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities – A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

Nipro Corporation (Nipro) carries out the manufacturing, development and sale of renal and medical surgical products. The company’s products find application in fields such as cardiology, urology and nephrology, interventional radiology and anesthesiology. Its product portfolio includes renal products, interventional and anesthesiology products, injection and infusion products, cardiopulmonary products, diabetic products and ENZYMES products among others. Nipro offers contract manufacturing services in various fields such as oral dosage forms and injection drugs, active pharmaceutical ingredients (APIs) and components. Nipro distributes its products through direct sales forces, sales companies in Germany, Turkey, Switzerland, England, Serbia, and South Africa and through distribution agent in South Korea. It has manufacturing facilities located in Japan, Brazil, Spain and the US. Nipro is headquartered in Osaka, Japan.

Nipro Corporation Key Recent Developments

Jun 06, 2016: GHIT Fund Welcomes Ten New Partnerships With FUJIFILM, Otsuka, GSK, Johnson & Johnson, Kyowa Hakko Kirin, Merck, Mitsubishi Tanabe, Nipro, Sumitomo Dainippon Pharma and Salesforce.com

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company
SECTION 1 - ABOUT THE COMPANY

Nipro Corporation - Key Facts
Nipro Corporation - Key Employees
Nipro Corporation - Major Products and Services
Nipro Corporation - Medical Equipment Pipeline Products Data
Nipro Corporation Pipeline Products by Equipment Type
Nipro Corporation Pipeline Products by Development Stage
Nipro Corporation - History
Nipro Corporation - Company Statement
Nipro Corporation - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Joint Venture

SECTION 2 – COMPANY ANALYSIS

Nipro Corporation - Business Description
Nipro Corporation - Corporate Strategy
Nipro Corporation - SWOT Analysis
SWOT Analysis - Overview
Nipro Corporation - Strengths
Strength - Business Performance: Medical-related segment
Strength - Operational Performance
Strength - Research and Development
Nipro Corporation - Weaknesses
Weakness - Increasing Debt Burden
Nipro Corporation - Opportunities
Opportunity - Growing Nephrology and Urology Devices Market
Opportunity - Product Approvals
Opportunity - Global Syringes and Needles Market
Nipro Corporation - Threats
Threat - Stiff Competition
Threat - Stringent Government Regulations
Threat - Rapid Technological Changes
Nipro Corporation - Key Competitors

SECTION 3 – COMPANY FINANCIAL RATIOS

Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts

SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES

Nipro Corporation, Medical Equipment, Deals By Year, 2010 to YTD 2016
Nipro Corporation, Medical Equipment, Deals By Type, 2010 to YTD 2016
Nipro Corporation, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016
Nipro Corporation, Pharmaceuticals & Healthcare, Deals By Type, 2010 to YTD 2016
Nipro Corporation, Recent Deals Summary

SECTION 5 – COMPANY’S RECENT DEVELOPMENTS

Mar 21, 2016: HealthLink Europe & International Opens A New FDA Registered, 100% Medical Warehouse Facility In Tennessee
Apr 27, 2015: One of the Most Important Global Healthcare Studies of this Generation Reaches Significant Patient Enrollment Milestone
Apr 01, 2015: HealthLink Europe receives ISO 13485 certificate for North American Medical warehouse
Mar 12, 2015: Infraredx Announces Launch of the New Advanced TVC Imaging System and TVC Muller Extended Bandwidth NIRS-IVUS Catheter at the American College of Cardiology 2015 Annual Meeting

SECTION 6 – APPENDIX

Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

LIST OF TABLES

Nipro Corporation, Key Facts
Nipro Corporation, Key Employees
Nipro Corporation, Major Products and Services
Nipro Corporation Pipeline Products by Equipment Type
Nipro Corporation Number of Pipeline Products by Development Stage
Nipro Corporation Pipeline Products Summary by Development Stage
Nipro Corporation, History
Nipro Corporation, Other Locations
Nipro Corporation, Subsidiaries
Nipro Corporation, Joint Venture
Nipro Corporation, Key Competitors
Nipro Corporation, Ratios based on current share price
Nipro Corporation, Annual Ratios
Nipro Corporation, Interim Ratios
Nipro Corporation, Medical Equipment, Deals By Year, 2010 to YTD 2016
Nipro Corporation, Medical Equipment, Deals By Type, 2010 to YTD 2016
Nipro Corporation, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016
Nipro Corporation, Pharmaceuticals & Healthcare, Deals By Type, 2010 to YTD 2016
Nipro Corporation, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

LIST OF FIGURES

Nipro Corporation Pipeline Products by Equipment Type
Nipro Corporation Pipeline Products by Development Stage
Nipro Corporation, Performance Chart (2012 - 2016)
Nipro Corporation, Ratio Charts
Nipro Corporation, Medical Equipment, Deals By Year, 2010 to YTD 2016
Nipro Corporation, Medical Equipment, Deals by Type, 2010 to YTD 2016
Nipro Corporation, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016
Nipro Corporation, Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016
Skip to top


Ask Your Question

Nipro Corporation (8086) - Financial and Strategic SWOT Analysis Review
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: